{"version":"1.0","provider_name":"Arbios","provider_url":"https:\/\/www.arbios.org\/en\/","title":"IXO Private Equity invests 2,7M\u20ac in Cyclopharma - Arbios","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"gc84t1UeeE\"><a href=\"https:\/\/www.arbios.org\/en\/ixo-private-equity-invests-27me-in-cyclopharma\/\">IXO Private Equity invests 2,7M\u20ac in Cyclopharma<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.arbios.org\/en\/ixo-private-equity-invests-27me-in-cyclopharma\/embed\/#?secret=gc84t1UeeE\" width=\"600\" height=\"338\" title=\"&#8220;IXO Private Equity invests 2,7M\u20ac in Cyclopharma&#8221; &#8212; Arbios\" data-secret=\"gc84t1UeeE\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.arbios.org\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2017\/05\/graph-163509_1280.jpg","thumbnail_width":1280,"thumbnail_height":720,"description":"[vc_row][vc_column][vc_column_text]Created in 2000 on the Biopole Clermont-Limagne, Cyclopharma is the French leader specialized in the development and the marketing of solutions of molecular imaging for the management of the patient both in oncology and in neurology. The capital increase will so allow to finance the research for new molecules biomarkers and the development of its [&hellip;]"}